Internal Medicine, Hematology & Oncology · Nashville, TN
NPI
1306070131
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3601 the Vanderbilt Clinic
Nashville, TN, 37232
Phone (615) 322-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
554 services
Medicare patients, 2024
218
Average age 74
Drug cost, 2024
$2.9M
756 prescriptions
Company payments, 2025
$20.47
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura E Ramirez was code 99214 (office e&m - established), 305 times for 148 patients. In total Laura E Ramirez billed 554 services in 11 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 305 | 148 | $67.79 | $21K |
| 99215 Office E&M - Established | Office | 108 | 51 | $109.70 | $12K |
| 99205 Office E&M - New | Office | 56 | 56 | $121.46 | $6,802 |
| 99213 Office E&M - Established | Office | 33 | 29 | $52.30 | $1,726 |
| 99204 Office E&M - New | Office | 28 | 28 | $87.46 | $2,449 |
By year: 2022 $23K for 283 services; 2023 $37K for 450 services; 2024 $45K for 554 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura E Ramirez prescribed most often to Medicare patients was Eliquis (Apixaban), with 48 prescriptions and refills. In total Laura E Ramirez wrote 756 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 48 | 88 | 15 | $50K |
| Dexamethasone Generic | 37 | 43 | 14 | $651 |
| Warfarin Sodium Generic | 33 | 90 | Under 11 | $261 |
| Oxycodone Hcl Generic | 28 | 28 | 13 | $703 |
| Prednisone Generic | 28 | 50 | 11 | $220 |
| Ondansetron Hcl Generic | 27 | 27 | 18 | $300 |
| Gabapentin Generic | 27 | 47 | Under 11 | $586 |
| Ondansetron Odt Ondansetron | 27 | 27 | 15 | $741 |
| Kisqali Ribociclib Succinate | 22 | 22 | Under 11 | $369K |
| Abiraterone Acetate Generic | 21 | 21 | Under 11 | $73K |
| Prochlorperazine Maleate Generic | 19 | 19 | 15 | $470 |
| Jakafi Ruxolitinib Phosphate | 18 | 18 | Under 11 | $277K |
| Revlimid Lenalidomide | 15 | 15 | Under 11 | $261K |
| Pantoprazole Sodium Generic | 14 | 30 | Under 11 | $159 |
| Kisqali Femara Co-Pack Ribociclib Succinate/Letrozole | 14 | 14 | Under 11 | $231K |
Brand drugs: 244 claims; generic drugs: 512 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura E Ramirez $20.47 ($20.47 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $20.47.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $20.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.